Ibex Investors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,382
Closed -$202K 213
2018
Q3
$202K Buy
+4,382
New +$202K 0.11% 173